AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

IMRICOR MEDICAL SYSTEMS-CDI

1.195

-0.005-0.42%

Volume:307.95K

Turnover:362.16K

Market Cap:382.93M

PE:-5.88

High:1.210

Open:1.195

Low:1.145

Close:1.200

Loading ...

Overview Company News Filings

Imricor Share Slide 'Complete Overreaction', Morgans Financial Says

MT Newswires Live

Why Imricor, Ora Banda, Ventia, and Vulcan shares are dropping today

Institutions along with individual investors who hold considerable shares inImricor Medical Systems, Inc. (ASX:IMR) come under pressure; lose 16% of holdings value

Simply Wall St.

ASX Biggest Losers

MT Newswires Live

Imricor Wins EU Nod for Products, Submits US FDA Notifications for Mapping System; Shares Fall 19%

MT Newswires Live

Notification regarding unquoted securities - IMR-IMR.AX

Morgans says these small cap ASX shares can rise 40% to 100%

Imricor Medical Systems Receives CE Mark Certification for Mapping System; Shares Up 5%

MT Newswires Live

Imricor Medical Systems Inc - Receives Ce Mark Approval for Northstar

THOMSON REUTERS

Imricor Medical Systems Says Hungary Hospital Performs First Atrial Ablations

MT Newswires Live

Imricor Commences VISABL-VT Trial

Imricor Medical Systems Says Consumables Revenue up 385% Year-Over-Year in March Quarter, Shares Rise 5%

MT Newswires Live

BUZZ-Australia's Imricor rises as Q1 revenue sees near fourfold jump

Why Imricor, Nanosonics, Perpetual, and Tourism Holdings shares are sinking today

Imricor Receives CE Mark Approval for Electrophysiology Recording, Cardiac Simulator System; Shares Fall 4%

MT Newswires Live

Why Antipa, Imricor, Lynas, and Newmont shares are pushing higher today

Imricor Medical Systems Starts Clinical Trial at Amsterdam Medical Center

MT Newswires Live

BRIEF-Imricor Medical Systems To Raise A$70.0 Mln

Imricor Medical Systems Inc - to Raise a$70.0 Mln at an Offer Price of a$1.41 per Share

THOMSON REUTERS

Imricor Medical Systems Inc-Proposed Issue of Securities - Imr

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IMR.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","market":"AU","secType":"STK","nameCN":"IMRICOR MEDICAL SYSTEMS-CDI","latestPrice":1.195,"timestamp":1752646320000,"preClose":1.2,"halted":0,"volume":307946,"delay":0,"nameEN":"IMRICOR MEDICAL SYSTEMS-CDI","floatShares":275046474,"shares":320446352,"eps":-0.20320885946906345,"marketStatus":"Not Yet Opened","change":-0.005,"latestTime":"07-16 16:12:00 AEST","open":1.195,"high":1.21,"low":1.145,"amount":362161,"amplitude":0.054167,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.20320885946906345,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1752710400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":1.2,"openAndCloseTimeList":[[1752624000000,1752645600000]],"volumeRatio":0.31706256326881593,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","floatShares":275046474,"roa":"-68.06%","roe":"-274.56%","lyrEps":-0.203209,"volumeRatio":0.31706256326881593,"shares":320446352,"dividePrice":0,"high":1.21,"amplitude":0.054167,"preClose":1.2,"low":1.145,"week52Low":0.46,"pbRate":"-33.86","psRate":"260.36","week52High":1.855,"institutionHeld":0,"latestPrice":1.195,"eps":-0.20320885946906345,"divideRate":0,"volume":307946,"delay":0,"ttmEps":-0.20320885946906345,"open":1.195,"prevYearClose":1.36,"prevWeekClose":1.265,"prevMonthClose":1.52,"prevQuarterClose":1.52,"fiveDayClose":1.555,"twentyDayClose":1.52,"sixtyDayClose":1.47},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMR.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2550983279","title":"Imricor Share Slide 'Complete Overreaction', Morgans Financial Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2550983279","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550983279?lang=en_us&edition=fundamental","pubTime":"2025-07-11 14:21","pubTimestamp":1752214876,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  fell past 4% in Friday trade, a \"complete overreaction\", after the company reported a delay in US regulatory progress, despite positive developments in Europe, according to a Thursday note by Morgans Financials.On Wednesday, the company said it received European medical device regulation approval for its products, including its NorthStar mapping system, ablation catheter, and capital equipment.The company added that the US Food and Drug Administration has reassigned the reviewer for its second Premarket Approval  module, which covers only the ablation catheter and RF generator.However, the company said it does not expect the PMA delay to materially impact its commercial trajectory.Morgans said the company has several upcoming catalysts over the next few quarters, including expected US approval of NorthStar, which will drive the share price.Morgans Financial maintained Imricor's speculative buy rating.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7503","IMR.AU","BK7007"],"gpt_icon":0},{"id":"2550160232","title":"Why Imricor, Ora Banda, Ventia, and Vulcan shares are dropping today","url":"https://stock-news.laohu8.com/highlight/detail?id=2550160232","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550160232?lang=en_us&edition=fundamental","pubTime":"2025-07-11 10:27","pubTimestamp":1752200829,"startTime":"0","endTime":"0","summary":"TheS&P/ASX 200 Index(ASX: XJO) has given back its early gains and is on course to end the week in the red. In afternoon trade, the benchmark is down 0.25% to 8,568.2 points. Four ASX shares that are f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/07/11/why-imricor-ora-banda-ventia-and-vulcan-shares-are-dropping-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7095","VNT.AU","BK7055","SSM.AU","XJO.AU","BK7508","IMR.AU","VUL.AU","BK7007","BK7504","OBM.AU","BK7503","BK7104"],"gpt_icon":0},{"id":"2550672182","title":"Institutions along with individual investors who hold considerable shares inImricor Medical Systems, Inc. (ASX:IMR) come under pressure; lose 16% of holdings value","url":"https://stock-news.laohu8.com/highlight/detail?id=2550672182","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550672182?lang=en_us&edition=fundamental","pubTime":"2025-07-11 04:43","pubTimestamp":1752180188,"startTime":"0","endTime":"0","summary":"Key Insights Imricor Medical Systems' significant individual investors ownership suggests that the key decisions are...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-imr/imricor-medical-systems-shares/news/institutions-along-with-individual-investors-who-hold-consid-208","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7508","BK7503","IMR.AU","BK7007"],"gpt_icon":0},{"id":"2550934736","title":"ASX Biggest Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2550934736","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550934736?lang=en_us&edition=fundamental","pubTime":"2025-07-10 10:25","pubTimestamp":1752114308,"startTime":"0","endTime":"0","summary":"Here are the 10 ASX-listed companies with the biggest losses on Thursday.Arcadia Minerals : -28%, AU$0.018Adavale Resources : -19%, AU$0.025Imricor Medical Systems : -18%, AU$1.28Pantera Lithium : -17%, AU$0.02Australian Pacific Coal : -16%, AU$0.016Stavely Minerals : -14%, AU$0.012Vital Metals : -13%, AU$0.096North Stawell Minerals : -10%, AU$0.035Credit Clear : -10%, AU$0.22Delta Lithium : -10%, AU$0.163","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7095","BK7016","IMR.AU","AQC.AU","BK7129","BK7508","SVY.AU","ADD.AU","DLI.AU","AM7.AU","BK7503","BK7007","NSM.AU","VML.AU","PFE.AU","BK7104","CCR.AU"],"gpt_icon":0},{"id":"2550569357","title":"Imricor Wins EU Nod for Products, Submits US FDA Notifications for Mapping System; Shares Fall 19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550569357","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550569357?lang=en_us&edition=fundamental","pubTime":"2025-07-10 10:14","pubTimestamp":1752113681,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  received European medical device regulation approval for its products, including its NorthStar mapping system, ablation catheter, and capital equipment, according to a Thursday filing with the Australian bourse.The company also submitted to the US Food and Drug Administration premarket notifications for NorthStar, with approval expected in the year, the filing said.Other pieces of capital equipment and devices remain on track for submissions and approval by the end of next year, the filing added.Shares of the company fell past 19% in recent Thursday trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7007","BK7503","BK4156","IMR.AU"],"gpt_icon":0},{"id":"2548844182","title":"Notification regarding unquoted securities - IMR-IMR.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2548844182","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548844182?lang=en_us&edition=fundamental","pubTime":"2025-07-03 08:51","pubTimestamp":1751503900,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250703:nASX6nfKgf","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250703:nASX176q2y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","BK7508","IMR.AU","BK7503"],"gpt_icon":0},{"id":"2543622570","title":"Morgans says these small cap ASX shares can rise 40% to 100%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543622570","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543622570?lang=en_us&edition=fundamental","pubTime":"2025-06-16 16:08","pubTimestamp":1750061329,"startTime":"0","endTime":"0","summary":"If you have a high tolerance for risk, it could be worth having some small cap ASX shares in a balanced portfolio. After all, the potential returns on offer at the small side of the market are much greater than at the large cap side. But which small cap ASX shares could be buys for investors?Let's take a look at two that analysts at Morgans are bullish on. Here's what they are recommending: Findi Ltd  This India-focused payments company could be a small cap ASX share to buy according to Morgans. It was relatively pleased with its recent FY 2025 results and believes the company is well-placed for growth over the long term. Particularly given the company's overall build out. It said:  FND's FY25 revenue beat guidance expectations ., whilst reported EBITDA came in at the mid-point of guidance . We saw this as a somewhat mixed result. While the headline numbers faired well versus guidance parameters they were assisted by higher \"other income.\" More positively F25 Operating cashflow generat","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/06/16/morgans-says-these-small-cap-asx-shares-can-rise-40-to-100/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7007","BK7508","BK7503","FND.AU","BK7043","BK7158","IMR.AU"],"gpt_icon":0},{"id":"2542351328","title":"Imricor Medical Systems Receives CE Mark Certification for Mapping System; Shares Up 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542351328","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542351328?lang=en_us&edition=fundamental","pubTime":"2025-06-10 08:53","pubTimestamp":1749516830,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  received CE Mark certification for its NorthStar mapping system under the European Union Medical Device Regulation, classifying it as a class IIa medical device, according to a Tuesday filing with the Australian bourse.This approval allows the company to market NorthStar across Europe and the Middle East, the filing said.Shares rose past 5% in morning trade Tuesday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CE","BK4109","IMR.AU","BK4588","BK7007","BK4585","BK7503","BK7508"],"gpt_icon":0},{"id":"2542531013","title":"Imricor Medical Systems Inc - Receives Ce Mark Approval for Northstar","url":"https://stock-news.laohu8.com/highlight/detail?id=2542531013","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542531013?lang=en_us&edition=fundamental","pubTime":"2025-06-10 06:38","pubTimestamp":1749508684,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nFWN3SC0JK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","BK7508","IMR.AU","BK7503"],"gpt_icon":0},{"id":"2532014342","title":"Imricor Medical Systems Says Hungary Hospital Performs First Atrial Ablations","url":"https://stock-news.laohu8.com/highlight/detail?id=2532014342","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532014342?lang=en_us&edition=fundamental","pubTime":"2025-05-01 08:56","pubTimestamp":1746060977,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  said Semmelweis University's Heart and Vascular Center in Hungary performed its first atrial flutter ablations guided by real-time magnetic resonance imaging, through the company's NorthStar 3D mapping system, according to a Thursday filing with the Australian bourse.The company aims for continued expansion and growth across Europe, including adding more sites to the VISABL-VT clinical trial, the filing said.Imricor Medical Systems shares rose past 2% in morning trade Thursday.Price : $1.66, Change: $+0.040, Percent Change: +2.47%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7503","IMR.AU","BK7007","BK7508"],"gpt_icon":0},{"id":"2529504436","title":"Imricor Commences VISABL-VT Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2529504436","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529504436?lang=en_us&edition=fundamental","pubTime":"2025-04-23 19:55","pubTimestamp":1745409300,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS, April 23, 2025----Imricor Medical Systems, Inc.   is pleased to announce that it has commenced the VISABL-VT clinical trial by completing the first-in-human ventricular ablation guided by real-time MRI with the Company’s NorthStar Mapping System. The procedure was performed by the team at the Amsterdam University Medical Centre , ranked in 2025 by Newsweek as the best hospital in The Netherlands, and in the top 35 worldwide.The procedure marked several world firsts. It was the first ventricular ablation to be guided by real-time MRI, and it was the first left-sided ablation to be performed under real-time MRI guidance. The patient was treated for right-sided and left-sided premature ventricular complexes .Imricor’s Chair and CEO, Steve Wedan, commented, \"We formed Imricor in 2006 with the goal of delivering MRI-compatible catheters and systems that would enable real-time MRI guidance of complex ventricular and atrial ablation procedures, where the power of MRI has the pote","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/imricor-commences-visabl-vt-trial-115500347.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7007","AUMC","IMR.AU","BK4588","BK4168","BK4585","VT","BK7508","BK7503"],"gpt_icon":0},{"id":"2529086592","title":"Imricor Medical Systems Says Consumables Revenue up 385% Year-Over-Year in March Quarter, Shares Rise 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529086592","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529086592?lang=en_us&edition=fundamental","pubTime":"2025-04-23 09:50","pubTimestamp":1745373002,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  reported a total revenue of $132,000 for the March quarter, with its consumables revenue of $104,000 up 385% year-over-year, according to a Wednesday Australian bourse filing.The firm reported net cash inflows from financing activities of $43 million in the March quarter, comprising net proceeds from the completion of the placement. Meanwhile, its net cash outflows from operating activities came in at $4.6 million.It also established Imricor BV, a wholly-owned subsidiary in the Netherlands, during the quarter. It hired the first capital sales managers in the US in preparation for a US commercial launch.On April 10, the first-in-man ventricular ablation guided by real-time interventional cardiac magnetic resonance was performed at the Amsterdam University Medical Centre.Its shares rose 5% in recent trading on Wednesday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMR.AU"],"gpt_icon":0},{"id":"2529591312","title":"BUZZ-Australia's Imricor rises as Q1 revenue sees near fourfold jump","url":"https://stock-news.laohu8.com/highlight/detail?id=2529591312","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529591312?lang=en_us&edition=fundamental","pubTime":"2025-04-23 09:20","pubTimestamp":1745371209,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Imricor rises as Q1 revenue sees near fourfold jump** Shares of Imricor IMR.AX rise 5.71% to A$1.48, their biggest intraday pct gain since April 11** The medical device developer says its consumables revenue in Q1 up 385% Y-O-Y at $104,000 ** Stock hits its highest level since April 16 ** Stock up 8.82% this year, including the day's move  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nL4N3R103U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMR.AU"],"gpt_icon":0},{"id":"2528573084","title":"Why Imricor, Nanosonics, Perpetual, and Tourism Holdings shares are sinking today","url":"https://stock-news.laohu8.com/highlight/detail?id=2528573084","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528573084?lang=en_us&edition=fundamental","pubTime":"2025-04-17 12:04","pubTimestamp":1744862698,"startTime":"0","endTime":"0","summary":"In afternoon trade, theS&P/ASX 200 Index (ASX: XJO) is on course to record a decent gain. At the time of writing, the benchmark index is up 0.6% to 7,803.9 points. Four ASX shares that have failed to ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/17/why-imricor-nanosonics-perpetual-and-tourism-holdings-shares-are-sinking-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7062","BK7508","BK7007","BK7503","MDR.AU","PPT.AU","XJO.AU","BK7125","BK7094","BK7126","BK7161","THL.AU","IMR.AU","NAN.AU"],"gpt_icon":0},{"id":"2528355757","title":"Imricor Receives CE Mark Approval for Electrophysiology Recording, Cardiac Simulator System; Shares Fall 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528355757","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528355757?lang=en_us&edition=fundamental","pubTime":"2025-04-17 10:51","pubTimestamp":1744858297,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  said that its Advantage-MR electrophysiology recording and cardiac stimulator system received CE mark certification under the European Union's new medical device regulations regime, according to a Thursday Australian bourse filing.The commercial launch of its second-generation Vision-MR ablation catheter and the new Advantage-MR system is planned to start in June across new and existing sites in the EU.In February, the company's second-generation Vision-MR ablation catheter received CE mark approval under the medical device regulations regime.Imricor's shares fell almost 4% in recent trading on Thursday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4109","IMR.AU","BK7503","BK7508","CE","BK4588","BK7007"],"gpt_icon":0},{"id":"2526500507","title":"Why Antipa, Imricor, Lynas, and Newmont shares are pushing higher today","url":"https://stock-news.laohu8.com/highlight/detail?id=2526500507","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526500507?lang=en_us&edition=fundamental","pubTime":"2025-04-11 13:30","pubTimestamp":1744349419,"startTime":"0","endTime":"0","summary":"In afternoon trade, theS&P/ASX 200 Index (ASX: XJO) has followed Wall Street's lead and dropped into the red. At the time of writing, the benchmark index is down 1.2% to 7,616.6 points. Four ASX share","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/11/why-antipa-imricor-lynas-and-newmont-shares-are-pushing-higher-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["AUMC","BK4168","BK7503","XJO.AU","BK7504","NEM.AU","BK7104","IGO.AU","BK7506","LYC.AU","BK7508","IMR.AU","BK7007","BK7095","AZY.AU","BK7507"],"gpt_icon":0},{"id":"2526521062","title":"Imricor Medical Systems Starts Clinical Trial at Amsterdam Medical Center","url":"https://stock-news.laohu8.com/highlight/detail?id=2526521062","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526521062?lang=en_us&edition=fundamental","pubTime":"2025-04-11 08:13","pubTimestamp":1744330432,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  started the VISABL-VT clinical trial after performing the first-in-human ventricular ablation guided by real-time interventional cardiac magnetic resonance  at the Amsterdam University Medical Center, according to a Friday filing with the Australian bourse.The trial evaluates the safety and effectiveness of radiofrequency ablation of ventricular tachycardia in ischemic cardiomyopathy using the Vision-MR Ablation Catheter 2.0 in the iCMR environment.The patient was treated for both right-sided and left-sided premature ventricular complexes, the filing said.Ventricular ablation is a procedure used to treat ventricular tachycardia, a rapid, abnormal heartbeat.Price : $1.36, Change: $+0.18, Percent Change: +14.83%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","IMR.AU","BK7508","BK7503"],"gpt_icon":0},{"id":"2520110201","title":"BRIEF-Imricor Medical Systems To Raise A$70.0 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2520110201","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520110201?lang=en_us&edition=fundamental","pubTime":"2025-03-20 08:52","pubTimestamp":1742431963,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems To Raise A$70.0 MlnMarch 20 (Reuters) - Imricor Medical Systems Inc IMR.AX:TO RAISE A$70.0 MILLION AT AN OFFER PRICE OF A$1.41 PER SHAREFurther company coverage: IMR.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nFWN3Q218N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7503","BK7508","BK7007","IMR.AU"],"gpt_icon":0},{"id":"2520118357","title":"Imricor Medical Systems Inc -  to Raise a$70.0 Mln at an Offer Price of a$1.41 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2520118357","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520118357?lang=en_us&edition=fundamental","pubTime":"2025-03-20 06:39","pubTimestamp":1742423963,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nFWN3Q218N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7503","BK7007","BK7508","IMR.AU"],"gpt_icon":0},{"id":"2520118350","title":"Imricor Medical Systems Inc-Proposed Issue of Securities - Imr","url":"https://stock-news.laohu8.com/highlight/detail?id=2520118350","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520118350?lang=en_us&edition=fundamental","pubTime":"2025-03-20 06:39","pubTimestamp":1742423946,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nTUE2ZKRXZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","IMR.AU","BK7503","BK7007"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":30,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMR.AU\",params:#limit:5,,,undefined,":[{"date":"2025-02-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-28","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724803200000,"name":null,"time":"","dateTimestamp":1724767200000,"actualEps":null},{"date":"2024-04-30","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1714435200000,"name":null,"time":"","dateTimestamp":1714399200000,"actualEps":null},{"date":"2024-02-29","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1709161200000,"name":null,"time":"","dateTimestamp":1709125200000,"actualEps":null},{"market":"AU","date":"2024-02-05","symbol":"IMR.AU","defaultRemindTime":1707087600000,"type":"split","dateTimestamp":1707051600000,"forFactor":968436,"toFactor":1000000,"ratio":0.968436}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMR.AU\",market:\"AU\",,,undefined,":[]}}